See every side of every news story
Published loading...Updated

Metformin Activates Tumor-Fighting T Cells in Mice, Suggesting Potential Role in Cancer Immunotherapy - Gilmore Health News

Summary by Gilmore Health News
Key Takeaways Metformin boosted CD8+ T cell activity in mice by increasing mitochondrial ROS and promoting immune cell growth. The anti-tumor effect wasn’t due to apoptosis, but to immune system modulation via interferon-γ secretion. Findings are preclinical — no human data yet, and the study didn’t test interactions with real-world cancer treatments. A team of  Okayama University scientists just helped shed light on an often proposed but poorly…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Gilmore Health News broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.